75 results
8-K
EX-99.1
ZOM
Zomedica Corp
15 Mar 24
Zomedica Provides Corporate NYSE American Listing Update
7:46am
pandemic and its impact upon our business operations generally, including our ability to develop and commercialize our products, and the other risk factors
DEFA14A
ZOM
Zomedica Corp
6 Feb 24
Additional proxy soliciting materials
5:14pm
products, the use of our products, intellectual property protection, risks related to the COVID-19 pandemic and its impact upon our business operations
DEFA14A
ZOM
Zomedica Corp
31 Jan 24
Additional proxy soliciting materials
8:00am
to the COVID-19 pandemic and its impact upon our business operations generally, including our ability to develop and commercialize our products, and the other
DEFA14A
ZOM
Zomedica Corp
26 Jan 24
Additional proxy soliciting materials
12:00am
, risks related to the COVID-19 pandemic and its impact upon our business operations generally, including our ability to develop and commercialize our
DEFA14A
zbbz3
17 Jan 24
Additional proxy soliciting materials
4:01pm
8-K
EX-99.1
8lhgj
10 Oct 23
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99.1
3695kjbn8st2
13 Sep 23
Zomedica Provides Corporate Update
5:58pm
8-K
EX-99.1
te0ramivt 6o
6 Sep 23
Zomedica Closes Acquisition of Structured Monitoring Products adding revolutionary
8:18am
8-K
EX-99.1
w4uq7k44 kse9p2dur05
11 May 23
Results of Operations and Financial Condition
4:27pm
8-K
EX-99.1
fsfbt bzx310i875
9 May 23
Other Events
8:57am
8-K
EX-99.1
66mmepzodmm a80
14 Nov 22
Results of Operations and Financial Condition
4:24pm
8-K
EX-99.1
q33cr
24 Aug 22
Zomedica Appoints Dr. Pamela Nichols, DVM to Board of Directors
4:57pm
8-K
EX-99.1
78z3w blt
15 Aug 22
Zomedica Announces Second Quarter 2022 Financial Results of $4.2 Million
6:12pm